Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Sep 2028 Index Fund
Direct Plan · Growth · Edelweiss Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +0.26% | +3.19% | 228 of 283 |
| 1M | +0.27% | +2.85% | 226 of 283 |
| 3M | +0.65% | -2.37% | 69 of 283 |
| 6M | +2.51% | +1.56% | 89 of 278 |
| YTD | +3.55% | -0.86% | 76 of 283 |
| 1Y | +4.58% | -0.15% | 59 of 263 |
| 2Y | +6.58% | +2.58% | 30 of 193 |
| 3Y | +7.49% | +9.71% | 75 of 142 |
| INCEPTION | +7.38% | — | — |
Ranked among: Other Scheme - Index Funds.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +1.84% | +3.99% | +0.05% | 100% | 41% |
| 6M | +3.72% | +6.06% | +1.52% | 100% | 41% |
| 1Y | +7.79% | +10.92% | +4.11% | 100% | 43% |
| 2Y | +8.11% | +9.07% | +6.48% | 100% | 43% |
| 3Y | +7.75% | +8.33% | +7.07% | 100% | 43% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity0.00%
- Debt96.74%
- Cash3.26%
- Other0.00%
Market Cap Split
- Large Cap0.00%
- Mid Cap0.00%
- Small Cap0.00%
- Others100.00%
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| 8.47% GUJARAT SDL RED 21-08-2028 | Debt | 39.19% | -0.77% |
| 738GOI2027 | Debt | 26.56% | +2.57% |
| 706GS28M23 | Debt | 20.29% | -0.21% |
| 815TN2028 | Debt | 9.75% | +1.81% |
| Accrued Interest | Net Current Assets | 1.91% | — |
| Clearing Corporation of India Ltd. | Net Current Assets | 1.37% | — |
| 613GOI2028 | Debt | 0.95% | +0.17% |
| Net Receivables/(Payables) | Net Current Assets | -0.02% | — |
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 0.98 | 12.38 | Low Volatility |
| 3Y | 1.06 | 10.25 | Low Volatility |
What is this?
Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.94 | -0.51 | Below Average |
| 3Y | 1.07 | 0.26 | Above Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 8.03 | 12.56 | Below Average |
| 3Y | 15.26 | 8.16 | Above Average |
What is this?
Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.
Tracking Difference
Versus CRISIL IBX 50:50 Gilt Plus SDL Sep 2028 Index, as of Sep 2026.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
ICICI Prudential Nifty Pharma Index Fund
Direct Plan · IDCW
|
+22.53% | +22.50% | — | +21.44% |
|
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund
Direct Plan · Growth
|
+20.88% | +21.50% | +14.91% | +16.74% |
|
Tata Nifty Capital Markets Index Fund
Direct Plan · Growth Option
|
+19.89% | — | — | +21.71% |
|
Motilal Oswal Nifty Capital Market Index Fund
Regular Plan · Growth
|
+19.31% | — | — | +16.06% |
|
Motilal Oswal S&P 500 Index Fund
Direct Plan · GROWTH
|
+18.19% | +25.74% | +16.20% | +20.46% |
|
Tata Nifty MidSmall Healthcare Index Fund
Regular Plan · IDCW Payout Option
|
+17.24% | — | — | +17.73% |
|
Motilal Oswal Nifty MidSmall Healthcare Index Fund
Regular Plan · Growth
|
+17.19% | — | — | +11.55% |
|
ICICI Prudential NASDAQ 100 Index Fund
Regular Plan · Growth
|
+15.21% | +27.99% | +16.74% | +17.49% |
|
Bandhan BSE Healthcare Index Fund
Regular Plan · Growth
|
+13.22% | — | — | +7.26% |
|
Motilal Oswal Nifty India Defence Index Fund
Regular Plan · Growth
|
+13.06% | — | — | +4.19% |
More From Edelweiss Asset Management Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Edelweiss US Value Equity Offshore Fund
Direct Plan · Growth
|
+29.74% | +21.68% | +14.03% | +13.46% |
| Edelweiss Silver ETF | +26.32% | — | — | +35.41% |
|
Edelweiss Gold and Silver ETF FOF
Direct Plan · Growth
|
+23.25% | +34.17% | — | +30.69% |
|
Edelweiss Emerging Markets Opportunities Equity Offshore Fund
Direct Plan · Growth
|
+22.43% | +25.06% | +9.43% | +11.36% |
|
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund
Direct Plan · Growth
|
+20.88% | +21.50% | +14.91% | +16.74% |
|
Edelweiss Recently Listed IPO Fund
Direct Plan · Growth
|
+20.01% | +17.71% | +10.98% | +15.60% |
| Edelweiss Gold ETF | +16.79% | — | — | +31.46% |
|
Edelweiss Europe Dynamic Equity Offshore Fund
Direct Plan · Growth
|
+16.72% | +25.29% | +14.57% | +13.15% |
|
Edelweiss ASEAN Equity Off-shore Fund
Direct Plan · Growth
|
+6.68% | +14.36% | +7.41% | +8.53% |
|
Edelweiss Equity Savings Fund
Direct Plan · Growth
|
+6.67% | +11.23% | +9.52% | +10.47% |
About This Scheme
Investment Objective
The investment objective of the scheme is to replicate CRISIL IBX 50:50 Gilt Plus SDL Index – Sep 2028 by investing in Indian Government Bonds and SDLs, maturing on or before September 28, 2028, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be realized, and the Scheme does not assure or guarantee any returns
Stated Asset Allocation
1. # Indian Government Bonds and SDLs representing CRISIL IBX 50:50 Gilt Plus SDL Index – Sep 2028 - 95-100% 2. Money Market Instruments - 0-5%
Exit Load
0.10% up to 30 days Nil after 30 days
Fund Managers
Mr Hetul Raval; Mr. Dhawal Dalal
Co-Manage
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch